Panel Discussion | Optimal Devices for the Treatment of CLI

Monday, March 10, 2025

11:58 AM – 12:15 PM ET

Panel Moderator(s)

Marianne Brodmann, MD

Head of Divsion of Angiology, Medical University Graz
Medical University Graz
Graz, Steiermark, Austria

Disclosure(s): No financial relationships to disclose
Gunnar Tepe, MD

Head of Department of Diagnostic and Interventional Radiology
Hospital of Rosenhein
Rosenheim, Germany

Disclosure(s): BBraun, Boston Scientific: Grant/Research Support (Ongoing)

Panel Discussant(s)

Eric J. Dippel, MD

Interventional Cardiologist
Vascular Institute of the Midwest, PC
Bettendorf, Iowa, United States

Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Asahi Intecc, Japan: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Cordis, Endovascular Division: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Efemoral Medical, Inc.: Stock-privately held company (Ongoing); Kent Imaging: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Nectero, Inc.: Stock-privately held company (Ongoing); Philips: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Synterventions: Stock-privately held company (Ongoing); Terumo: Consulting Fees (e.g., advisory boards) (Ongoing); Versono: Consulting Fees (e.g., advisory boards) (Ongoing)
S. Jay Mathews, MD

Director, Cardiac Cath Lab, PERT, & Structural Heart
Manatee Memorial Hospital

Disclosure(s): Abbott Cardiovascular Systems: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Akura: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Bolt Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Cardiva: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); CONTEGO MEDICAL: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Cordis, Endovascular Division: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Evident Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Innova Vascular Inc: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Intellvasc: Consultant (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Philips: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Protexa: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Reflow Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Shockwave: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); W. L. Gore: Grant/Research Support (Ongoing)
Dipankar Mukherjee, MD

chief of vascular surgery
INOVA Fairfax Hospital
Vienna, Virginia, United States

Disclosure(s): No financial relationships to disclose
Jihad A. Mustapha, MD FACC FSCAI

Interventional Cardiologist
Lorven Heart & Vascular Institute
Ada , Michigan, United States

Disclosure(s): No financial relationships to disclose
Zola M. N'Dandu, MD

Interventional Cardiology and Endovascular Specialist
Ansaarie Cardiac and Endovascular Center of Excellence
St Augustine, Florida, United States

Disclosure(s): No financial relationships to disclose
Eric A. Secemsky, MD, MSc

Director of Vascular Intervention
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States

Disclosure(s): Abbott, BD, Boston Scientific, Cook, Cordis, Endovascular Engineering, Gore, InfraRedx, Medtronic, Philips, RapidAI, Rampart, Shockwave, Siemens, Teleflex, Terumo, Thrombolex, VentureMed, Zoll: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Nicolas W. Shammas, MD, MS

Founder, President and Research Director
Midwest Cardiovascular Research Foundation
Davenport, Iowa, United States

Disclosure(s): Abbott Vascular: Grant/Research Support (Ongoing); Angiodynamics: Consultant (Ongoing), Grant/Research Support (Ongoing); Bard Peripheral Vascular, Inc.: Consultant (Ongoing), Grant/Research Support (Ongoing); Shockwave Medical: Grant/Research Support (Ongoing)

Disclosure(s):

Marianne Brodmann, MD: No financial relationships to disclose

Gunnar Tepe, MD: BBraun, Boston Scientific: Grant/Research Support (Ongoing)

Eric J. Dippel, MD: Abbott Vascular, Medtronic, Boston Scientific: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Asahi Intecc, Japan: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Cordis, Endovascular Division: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Efemoral Medical, Inc.: Stock-privately held company (Ongoing); Kent Imaging: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Nectero, Inc.: Stock-privately held company (Ongoing); Philips: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Synterventions: Stock-privately held company (Ongoing); Terumo: Consulting Fees (e.g., advisory boards) (Ongoing); Versono: Consulting Fees (e.g., advisory boards) (Ongoing)

S. Jay Mathews, MD: Abbott Cardiovascular Systems: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Akura: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Bolt Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Cardiva: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); CONTEGO MEDICAL: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Cordis, Endovascular Division: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Evident Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Innova Vascular Inc: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Intellvasc: Consultant (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Philips: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Protexa: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Reflow Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Shockwave: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); W. L. Gore: Grant/Research Support (Ongoing)

Dipankar Mukherjee, MD: No financial relationships to disclose

Jihad A. Mustapha, MD FACC FSCAI: No financial relationships to disclose

Zola M. N'Dandu, MD: No financial relationships to disclose

Eric A. Secemsky, MD, MSc: Abbott, BD, Boston Scientific, Cook, Cordis, Endovascular Engineering, Gore, InfraRedx, Medtronic, Philips, RapidAI, Rampart, Shockwave, Siemens, Teleflex, Terumo, Thrombolex, VentureMed, Zoll: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Nicolas W. Shammas, MD, MS: Abbott Vascular: Grant/Research Support (Ongoing); Angiodynamics: Consultant (Ongoing), Grant/Research Support (Ongoing); Bard Peripheral Vascular, Inc.: Consultant (Ongoing), Grant/Research Support (Ongoing); Shockwave Medical: Grant/Research Support (Ongoing)